Cargando…

Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform

INTRODUCTION: COVID-19 is a new viral-induced pneumonia caused by infection with a novel coronavirus, SARS-CoV-2. At present, there are few proven effective treatments. This early-phase experimental medicine protocol describes an overarching and adaptive trial designed to provide safety data in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaughan, Erin, Quinn, Tom, Bruce, Annya, Antonelli, Jean, Young, Vikki, Mair, Joanne, Akram, Ahsan, Hirani, Nik, Koch, Oliver, Mackintosh, Claire, Norrie, John, Dear, James W, Dhaliwal, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678561/ https://www.ncbi.nlm.nih.gov/pubmed/34911721 http://dx.doi.org/10.1136/bmjopen-2021-054442

Ejemplares similares

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
por: Gaughan, Erin E., et al.
Publicado: (2022)

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
por: Halatsch, Marc-Eric, et al.
Publicado: (2021)

Group IIA secretory phospholipase 2 independently predicts mortality and positive blood culture in emergency department sepsis patients
por: Nandi, Utsav, et al.
Publicado: (2021)

Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease
por: Megia-Fernandez, Alicia, et al.
Publicado: (2021)

Erratum to “Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease”
por: Megia-Fernandez, Alicia, et al.
Publicado: (2023)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Tolerance and efficacy of preoperative intracavitary HDR brachytherapy in IB and IIA cervical cancer
por: Bialas, Brygida, et al.
Publicado: (2009)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review
por: Lim, Nicole-Ann, et al.
Publicado: (2022)

A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome
por: Abreu, Damien, et al.
Publicado: (2021)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Activated neutrophil fluorescent imaging technique for human lungs
por: Craven, Thomas H., et al.
Publicado: (2021)

Defining and measuring suspicion of sepsis: an analysis of routine data
por: Inada-Kim, Matthew, et al.
Publicado: (2017)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Is the ovarian preservation safe in young women with stages IB–IIA villoglandular adenocarcinoma of the uterine cervix?
por: Ju, U Chul, et al.
Publicado: (2018)

Application of a High-Content Screening Assay Utilizing Primary Human Lung Fibroblasts to Identify Antifibrotic Drugs for Rapid Repurposing in COVID-19 Patients
por: Marwick, John A., et al.
Publicado: (2021)

Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
por: Quinn, Tom M., et al.
Publicado: (2022)

Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
por: Zhang, Weifeng, et al.
Publicado: (2019)

The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer
por: Zhang, Can, et al.
Publicado: (2019)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer
por: Beskow, C, et al.
Publicado: (2006)

Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer
por: Zhou, Juan, et al.
Publicado: (2015)

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer
por: An, Qiang, et al.
Publicado: (2020)

A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
por: Wu, Lei-Lei, et al.
Publicado: (2021)

MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results
por: Song, Qingling, et al.
Publicado: (2022)

Defining the function of OmpA in the Rcs stress response
por: Dekoninck, Kilian, et al.
Publicado: (2020)

Risk strata-based therapy and outcome in stage Ib–IIa carcinoma cervix: single-centre ten-year experience
por: Kundargi, Rajshekar S, et al.
Publicado: (2013)

Pretreatment C‐reactive protein/albumin ratio is associated with poor survival in patients with stage IB‐IIA cervical cancer
por: Zhang, Weiwei, et al.
Publicado: (2017)

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
por: Wu, San-Gang, et al.
Publicado: (2017)

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update
por: Landoni, Fabio, et al.
Publicado: (2017)

Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis
por: Yan, Ruo-nan, et al.
Publicado: (2020)

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study
por: Yan, Wenxing, et al.
Publicado: (2020)

Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer
por: Wang, Shan, et al.
Publicado: (2023)

Defining and identifying critical elements of, and lessons learned from addressing, ‘operational readiness’ for public health emergency events, including COVID-19: a scoping review protocol
por: English, Rene, et al.
Publicado: (2022)

Pakistan's COVID-19 Prevention and Control Response Using the World Health Organization's Guidelines for Epidemic Response Interventions
por: Emmanuel, Faran, et al.
Publicado: (2023)

Defining basic rules for hardening influenza A virus liquid condensates
por: Etibor, Temitope Akhigbe, et al.
Publicado: (2023)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_cmdp240gm3t4edqlutdjqdo5d6